Songita A Choudhury1, Feng Xie2, Paul A Dayton3, Thomas R Porter4. 1. Department of Cellular & Integrative Physiology, Division of Cardiology, University of Nebraska Medical Center, Omaha, Nebraska. 2. Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina. 3. Department of Biomedical Engineering, University of North Carolina, Chapel Hill, North Carolina. 4. Department of Cellular & Integrative Physiology, Division of Cardiology, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: trporter@unmc.edu.
Abstract
BACKGROUND: Commercially available microbubbles such as Definity contain octafluoropropane encapsulated in a lipid shell. This perfluorocarbon can be compressed into liquid nanodroplets at room temperatures and activated with transthoracic diagnostic ultrasound. The aim of this study was to determine the size range and acoustic characteristics of Definity nanodroplets (DNDs) compared with Definity microbubbles (DMBs). METHODS: An in vitro flow system was used with a diagnostic ultrasound transducer (S5-1, iE33). DMBs were prepared using package insert instructions. DNDs were prepared by cooling DMBs in a -10°C to -15°C isopropyl alcohol bath before hand-pressurizing the solution. The formed DNDs were sized, diluted to 1% solutions, and infused continuously into a phosphate-buffered saline solution running within Silastic tubing. Acoustic intensity (AI) was compared with equivalent dilutions of DMBs at different mechanical indices (MIs) ranging from 0.2 to 1.4 (n = 6 comparisons at each MI) using real-time 56-Hz and triggered 2-Hz frame rates (FRs). A 3-cm-thick tissue-mimicking phantom was used to simulate transthoracic attenuation. In vivo transthoracic studies were performed in four normal pigs infused with 10% intravenous infusions of DMBs or DNDs at real-time and triggered end-systolic FRs to compare differences in myocardial and left ventricular cavity AI. RESULTS: DNDs were smaller than DMBs and ranged in size from 50 to 1,000 nm. In vitro studies revealed that at an MI of 0.2 and an FR of 56 Hz, DMBs had high AI (37 ± 2 dB), but AI dropped to 25 ± 2 dB at an MI of 1.0 (P < .001, analysis of variance). In comparison, DNDs had virtually no AI at MIs of 0.2 to 0.6 at both triggered and 56-Hz FRs (1 ± 0 dB), but AI increased to 34 ± 2 dB at an MI of 1.4 using an FR of 56 Hz (P < .001 vs MI of 0.2). AI also persisted longer at 56 Hz with DNDs when using higher MIs. In vivo studies demonstrated higher myocardial AI for DNDs at higher MIs when using real-time FR, most likely from microvascular nanodroplet activation. CONCLUSION: These data indicate significant differences in acoustic responses of the commercially available DMBs when administered as an equivalent number of DNDs. The DND formulation may render them more useful for high-MI real-time imaging and other targeted transthoracic diagnostic applications.
BACKGROUND: Commercially available microbubbles such as Definity contain octafluoropropane encapsulated in a lipid shell. This perfluorocarbon can be compressed into liquid nanodroplets at room temperatures and activated with transthoracic diagnostic ultrasound. The aim of this study was to determine the size range and acoustic characteristics of Definity nanodroplets (DNDs) compared with Definity microbubbles (DMBs). METHODS: An in vitro flow system was used with a diagnostic ultrasound transducer (S5-1, iE33). DMBs were prepared using package insert instructions. DNDs were prepared by cooling DMBs in a -10°C to -15°C isopropyl alcohol bath before hand-pressurizing the solution. The formed DNDs were sized, diluted to 1% solutions, and infused continuously into a phosphate-buffered saline solution running within Silastic tubing. Acoustic intensity (AI) was compared with equivalent dilutions of DMBs at different mechanical indices (MIs) ranging from 0.2 to 1.4 (n = 6 comparisons at each MI) using real-time 56-Hz and triggered 2-Hz frame rates (FRs). A 3-cm-thick tissue-mimicking phantom was used to simulate transthoracic attenuation. In vivo transthoracic studies were performed in four normal pigs infused with 10% intravenous infusions of DMBs or DNDs at real-time and triggered end-systolic FRs to compare differences in myocardial and left ventricular cavity AI. RESULTS:DNDs were smaller than DMBs and ranged in size from 50 to 1,000 nm. In vitro studies revealed that at an MI of 0.2 and an FR of 56 Hz, DMBs had high AI (37 ± 2 dB), but AI dropped to 25 ± 2 dB at an MI of 1.0 (P < .001, analysis of variance). In comparison, DNDs had virtually no AI at MIs of 0.2 to 0.6 at both triggered and 56-Hz FRs (1 ± 0 dB), but AI increased to 34 ± 2 dB at an MI of 1.4 using an FR of 56 Hz (P < .001 vs MI of 0.2). AI also persisted longer at 56 Hz with DNDs when using higher MIs. In vivo studies demonstrated higher myocardial AI for DNDs at higher MIs when using real-time FR, most likely from microvascular nanodroplet activation. CONCLUSION: These data indicate significant differences in acoustic responses of the commercially available DMBs when administered as an equivalent number of DNDs. The DND formulation may render them more useful for high-MI real-time imaging and other targeted transthoracic diagnostic applications.
Authors: Ping Zeng; Cheng Chen; John Lof; Elizabeth Stolze; Shouqiang Li; Xucai Chen; John Pacella; Flordeliza S Villanueva; Terry Matsunaga; E Carr Everbach; Hongwen Fei; Feng Xie; Thomas Porter Journal: Ultrasound Med Biol Date: 2022-08-30 Impact factor: 3.694
Authors: Michael Cimorelli; Michael A Flynn; Brett Angel; Emily Reimold; Sahil S Banka; Benjamin Andrien; Aaron Fafarman; Richard Huneke; Andrew Kohut; Steven Wrenn Journal: J Cardiovasc Transl Res Date: 2022-01-31 Impact factor: 3.216
Authors: David G Ramirez; Mark Ciccaglione; Awaneesh K Upadhyay; Vinh T Pham; Mark A Borden; Richard K P Benninger Journal: Proc Natl Acad Sci U S A Date: 2021-10-12 Impact factor: 11.205
Authors: Ping Zeng; Lijun Qian; John Lof; Elizabeth Stolze; Soufiane El Kadi; Thomas Bargar; Jiri Sklenar; Terry Matsunaga; Feng Xie; Thomas R Porter Journal: J Am Soc Echocardiogr Date: 2021-03-09 Impact factor: 7.722
Authors: Songita A Choudhury; Feng Xie; Shelby Kutty; John Lof; Elizabeth Stolze; Thomas R Porter Journal: PLoS One Date: 2018-12-14 Impact factor: 3.240